P

Inventor

PAULS HEINZ W

CA46 patents
⚠️ This page may combine multiple inventors who share the name “PAULS HEINZ W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV HEALTH NETWORK

26 patents
US9657025B2May 23, 2017

Pyrazolopyrimidine compounds

UNIV HEALTH NETWORK11 citations92
US9573954B2Feb 21, 2017

Pyrazolopyrimidine compounds

UNIV HEALTH NETWORK13 citations92
US9139563B2Sep 22, 2015

Kinase inhibitors and method of treating cancer

UNIV HEALTH NETWORK14 citations92
US10472353B2Nov 12, 2019

Salt and crystal forms of PLK-4 inhibitor

UNIV HEALTH NETWORK3 citations84
US10392374B2Aug 27, 2019

Salt and crystal forms of PLK-4 inhibitor

UNIV HEALTH NETWORK3 citations84
US10358436B2Jul 23, 2019

Kinase inhibitors and method of treating cancer

UNIV HEALTH NETWORK4 citations84
US9907800B2Mar 6, 2018

Kinase inhibitors and method of treating cancer

UNIV HEALTH NETWORK7 citations84
US9884855B2Feb 6, 2018

Salt and crystal forms of PLK-4 inhibitor

UNIV HEALTH NETWORK8 citations84
US8999968B2Apr 7, 2015

Kinase inhibitors and method of treating cancer with same

UNIV HEALTH NETWORK13 citations84
US10106545B2Oct 23, 2018

Pyrazolopyrimidine compounds

UNIV HEALTH NETWORK4 citations83
US9796703B2Oct 24, 2017

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

UNIV HEALTH NETWORK4 citations83
US9579327B2Feb 28, 2017

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

UNIV HEALTH NETWORK5 citations83
US11104681B2Aug 31, 2021

Solid forms of TTK inhibitor

UNIV HEALTH NETWORK1 citations73
US10919886B2Feb 16, 2021

Salt and crystal forms of PLK-4 inhibitor

UNIV HEALTH NETWORK2 citations73
US10584130B2Mar 10, 2020

Solid forms of TTK inhibitor

UNIV HEALTH NETWORK2 citations73
USRE47731ENov 19, 2019

Kinase inhibitors and method of treating cancer with same

UNIV HEALTH NETWORK4 citations73
US10167289B2Jan 1, 2019

Pyrazolopyrimidine compounds

UNIV HEALTH NETWORK2 citations73
US10570143B2Feb 25, 2020

Pyrazolopyrimidine compounds

UNIV HEALTH NETWORK2 citations72
US10501474B2Dec 10, 2019

HPK1 inhibitors and methods of using same

UNIV HEALTH NETWORK3 citations72
US10077255B2Sep 18, 2018

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

UNIV HEALTH NETWORK2 citations72
US11878980B2Jan 23, 2024

Solid forms of TTK inhibitor

UNIV HEALTH NETWORK0 citations62
US11667627B2Jun 6, 2023

Salt and crystal forms of PLK-4 inhibitor

UNIV HEALTH NETWORK0 citations62
US11059832B2Jul 13, 2021

HPK1 inhibitors and methods of using same

UNIV HEALTH NETWORK0 citations62
US10875863B2Dec 29, 2020

RIPK2 inhibitors and method of treating cancer with same

UNIV HEALTH NETWORK0 citations49
US10239881B2Mar 26, 2019

RIPK2 inhibitors and method of treating cancer with same

UNIV HEALTH NETWORK0 citations49
US9580390B2Feb 28, 2017

Indazole compounds as kinase inhibitors and method of treating cancer with same

UNIV HEALTH NETWORK0 citations40

PAULS HEINZ W

5 patents

SYNTEX INC

2 patents

SAMPSON PETER B

2 patents

RHONE POULENC RORER PHARMA

2 patents

AFFINIUM PHARM INC

2 patents

AVENTIS PHARMA INC

2 patents

AVENTIS PHARM PROD INC

1 patent

AVENTIS PHARMA GMBH

1 patent

CUMMING GRAHAM

1 patent

SAMPSON PETER BRENT

1 patent

RESEARCH CORP

1 patent